The Impact of Short-Term Professional Continuous Glucose Monitoring on Glycemic Control Via Lifestyle Improvement

Diabetes Technology & Therapeutics
Ryo ShibusawaMasanobu Yamada

Abstract

The efficacy of short-term professional continuous glucose monitoring (CGM) for glycemic control in patients with diabetes remains unclear. We performed a 3-month study to evaluate the benefits of CGM in 64 patients. The overall glycemic control of patients who underwent CGM improved significantly; however, that of patients maintaining the same medications did not improve overall. Thirty-one patients with unchanged medications were divided into improved (n = 12) versus nonimproved (n = 19) groups. In the improved group, baseline hemoglobin A1c (HbA1c) levels were higher than in the nonimproved group (P = 0.0066) despite mean blood glucose levels remaining the same (P = 0.3406). The improved group also exhibited lower glucose variability. Patients with lower than expected mean glucose levels, based on HbA1c values, and patients with lower glucose level variability during CGM may be able to improve their glycemic control after lifestyle change without treatment modification.

References

Jan 7, 2000·Diabetes Research and Clinical Practice·B W BodeJ J Mastrototaro
Jun 10, 2008·Diabetes Care·David M NathanUNKNOWN A1c-Derived Average Glucose Study Group
Jan 20, 2016·Diabetes Technology & Therapeutics·David Rodbard
Nov 8, 2016·Journal of Diabetes and Its Complications·Robert Vigersky, Maneesh Shrivastav

❮ Previous
Next ❯

Software Mentioned

CareLink iPro
JMP

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.